Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166


Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment.

Bao B, Ali S, Ahmad A, Azmi AS, Li Y, Banerjee S, Kong D, Sethi S, Aboukameel A, Padhye SB, Sarkar FH.

PLoS One. 2012;7(12):e50165. doi: 10.1371/journal.pone.0050165. Epub 2012 Dec 13.


Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

Bao B, Ahmad A, Kong D, Ali S, Azmi AS, Li Y, Banerjee S, Padhye S, Sarkar FH.

PLoS One. 2012;7(8):e43726. doi: 10.1371/journal.pone.0043726. Epub 2012 Aug 27.


Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.

Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philip PA, Sarkar FH.

PLoS One. 2011 Mar 9;6(3):e17850. doi: 10.1371/journal.pone.0017850.


Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.

Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, Sarkar FH.

Cancer Res. 2012 Jan 1;72(1):335-45. doi: 10.1158/0008-5472.CAN-11-2182. Epub 2011 Nov 22.


Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH.

Cancer Lett. 2011 Aug 1;307(1):26-36. doi: 10.1016/j.canlet.2011.03.012. Epub 2011 Apr 3.


Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling.

Ali S, Ahmad A, Aboukameel A, Ahmed A, Bao B, Banerjee S, Philip PA, Sarkar FH.

Cancer Lett. 2014 Aug 28;351(1):134-42. doi: 10.1016/j.canlet.2014.05.013. Epub 2014 May 16.


Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH.

Cancer Prev Res (Phila). 2012 Mar;5(3):355-64. doi: 10.1158/1940-6207.CAPR-11-0299. Epub 2011 Nov 15.


Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, Wang Z, Philip PA, Sarkar FH.

Cancer Res. 2010 May 1;70(9):3606-17. doi: 10.1158/0008-5472.CAN-09-4598. Epub 2010 Apr 13.


Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3.

Boreddy SR, Sahu RP, Srivastava SK.

PLoS One. 2011;6(10):e25799. doi: 10.1371/journal.pone.0025799. Epub 2011 Oct 10.


Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.

Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH.

Cancer Lett. 2012 Jun 28;319(2):173-81. doi: 10.1016/j.canlet.2012.01.013. Epub 2012 Jan 17.


MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.

Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X.

Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.


Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW.

Lab Invest. 2006 Dec;86(12):1221-32. Epub 2006 Oct 30.


Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.

Chen MC, Lee CF, Huang WH, Chou TC.

Biochem Pharmacol. 2013 May 1;85(9):1278-87. doi: 10.1016/j.bcp.2013.02.009. Epub 2013 Feb 14.


The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.

Miyake K, Nishioka M, Imura S, Batmunkh E, Uto Y, Nagasawa H, Hori H, Shimada M.

Exp Cell Res. 2012 Aug 1;318(13):1554-63. doi: 10.1016/j.yexcr.2012.03.013. Epub 2012 Mar 24.


Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.

Nagaraju GP, Zhu S, Ko JE, Ashritha N, Kandimalla R, Snyder JP, Shoji M, El-Rayes BF.

Cancer Lett. 2015 Feb 28;357(2):557-65. doi: 10.1016/j.canlet.2014.12.007. Epub 2014 Dec 9.


Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.

Lee J, Park SY, Lee EK, Park CG, Chung HC, Rha SY, Kim YK, Bae GU, Kim BK, Han JW, Lee HY.

Clin Cancer Res. 2006 Nov 1;12(21):6351-8.


Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.

Takata K, Morishige K, Takahashi T, Hashimoto K, Tsutsumi S, Yin L, Ohta T, Kawagoe J, Takahashi K, Kurachi H.

Mol Cancer Ther. 2008 Jun;7(6):1551-61. doi: 10.1158/1535-7163.MCT-07-0428.


Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α.

Zhang Y, Liu Q, Wang F, Ling EA, Liu S, Wang L, Yang Y, Yao L, Chen X, Wang F, Shi W, Gao M, Hao A.

J Pineal Res. 2013 Sep;55(2):121-30. doi: 10.1111/jpi.12052. Epub 2013 Mar 29.


MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.

Sun X, Wei L, Chen Q, Terek RM.

Clin Orthop Relat Res. 2015 Mar;473(3):907-13. doi: 10.1007/s11999-014-3842-0.


Induction, modulation and potential targets of miR-210 in pancreatic cancer cells.

Chen WY, Liu WJ, Zhao YP, Zhou L, Zhang TP, Chen G, Shu H.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):319-24.

Items per page

Supplemental Content

Write to the Help Desk